Stay updated on Solanezumab vs Placebo in Alzheimer's Clinical Trial

Sign up to get notified when there's something new on the Solanezumab vs Placebo in Alzheimer's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Solanezumab vs Placebo in Alzheimer's Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The record describes a terminated Phase 3 study of solanezumab versus placebo for mild Alzheimer’s disease, including its eligibility criteria, study design, outcomes, and locations. It also provides study results and information on requesting access to individual participant data.
    Difference
    100%
    Check dated 2026-11-11T01:27:01.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0; the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T23:35:37.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    A notice about NIH website changes and the terminology shift from “Artificial Intelligence” to “Super Intelligence” was added. The displayed site revision changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T23:28:09.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The site revision label in the footer changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:23:14.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page content now shows a 403 error screen, replacing the previously visible study record information and navigation. This indicates access to the record is blocked.
    Difference
    17%
    Check dated 2026-09-23T00:32:55.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page revision was updated to v3.7.0, replacing the previous v3.6.6. This reflects an administrative update to the study record rather than a change to its substantive content.
    Difference
    0.0%
    Check dated 2026-09-15T23:37:23.000Z thumbnail image

Stay in the know with updates to Solanezumab vs Placebo in Alzheimer's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Solanezumab vs Placebo in Alzheimer's Clinical Trial page.